GEN Exclusives

More »

Feature Articles

More »
Sep 1, 2014 (Vol. 34, No. 15)

Optogenetics: Lightly Pressing the Cell’s Buttons

Engineering of Light Sensitivity into Specific Parts of Cells Enables Dissection of Signaling Pathways

  • “You can observe a lot just by watching,” said the accidental sage, leaving us to wonder whether he meant to celebrate the power or lament the futility of simply paying attention. Were he scientifically inclined, he might have added that mere observation is unsatisfying because many things can be learned only through experimentation—perturbing things, then seeing what happens next. So it is with cells: Once roused or stifled, cells may reveal much that would otherwise remain hidden.

    The idea is to enact “what if” scenarios instead of simply watching and waiting. The trick, however, is to perturb cells without being too heavy-handed, always a risk when cells are electrically jolted or chemically lesioned. The lightest touch, it turns out, may be an actual “light touch”—the use of illumination to alter the behaviors of selected cells. This is the essence of optogenetics.

    Optogenetics relies on proteins that alter their functions when they are exposed to light. These proteins, which are expressed naturally by various organisms, may be introduced to targeted cells within living organisms by means of genetic engineering. Then, by supplying illumination of the appropriate wavelength to sensitized cells, the researcher may incite or suppress selected biological processes.

    It is possible to perturb the cell’s biological processes at several levels. To date, most optogenetic studies have deployed light-sensitive ion channels or pumps, mostly in neurons. By switching specific populations of neurons on and off, scientists gain the ability to disentangle neural circuits and decode the brain’s electrical signaling. Membrane-bound, light-sensitive proteins have also been used to explore the cell’s internal signaling, the biochemical cascades triggered, for example, by G-protein coupled receptors.

    With optogenetics, it is also possible to “push buttons” beyond the cell membrane. Instead of using optogenetics to open or close an ion channel, researchers have created an optogenetic system that controls customized transcription machinery. This system relies on a light-sensitive protein that has been fused to a DNA-binding protein, a transcription activator-like effector (TALE), which may be customized to bind to selected regions of the genome. When illuminated, the protein-TALE complex is activated, and transcription commences. Thus, the light-sensitive protein and the TALE, used together, determine not only where, but when, transcription occurs. A similar system, one that would use CRISPR instead of TALE technology, has been proposed.

    Used at yet another level, optogenetics may activate or inactivate individual proteins that have been engineered to carry a bulky, artificial, light-sensitive amino acid. This amino acid, upon illumination, sheds a side chain to become cysteine, and the protein of which it is a part alters its shape and gains activity.

    One such protein was incorporated into an ion channel. The protein, at the flick of a light switch, jettisoned its artificial amino acid’s extra bulk, freeing the ion channel of an obstruction. Although this protein was used to optically open an ion channel, similar proteins could be devised to optically regulate protein modifications and protein-protein interactions.

  • Switching Neurons On and Off

    Optogenetics got its start in the 2000s, when neuroscientists began realizing a plan that had been outlined decades earlier by Francis Crick. Noting that electrodes could not distinguish between different cell types, Crick proposed in 1979 that what neuroscientists needed was a method that could activate or deactivate “all neurons of just one type … leaving the others more or less unaltered.” With such a method, neuroscientists could avoid the problem of activating conflicting neural pathways. Neuroscientists could finally dissect neural circuitry.

    Subsequently, Crick even suggested that light could serve as a control tool. At the time, however, various light-sensitive proteins were just beginning to be characterized. In the early 1970s, researchers identified bacteriorhodopsin as a light-activated ion pump and the first of what was to become an expanding palette of so-called microbial opsins. Bacteriorhodopsin was soon joined by halorhodopsin and channelrhodopsin. In addition, engineered variants of these molecules eventually appeared.

    The advantage of microbial opsins is that they are single-component systems—they combine light sensitivity and effector function in a single protein. Although the protein requires a cofactor, retinal, this cofactor naturally occurs in animal tissues. In fact, in all animal tissues tested to date, retinal is present in such quantities that no retinal supplementation is needed. And so, a microbial opsin optogenetic system need deploy only a microbial opsin gene and a suitable promoter. (Multicomponent systems, in contrast, deploy not microbial opsin genes but rather combinations of different genes that are sometimes accompanied by custom-synthesized chemicals.)

    A lucky break, to be sure. But luck has had little to do with the development of optogenetics. Without its enabling technologies, optogenetics would have remained little more than an intriguing notion. These technologies encompass microbial opsins; gene constructs (including promoters, viral vectors, and transgene lines); and light-delivery and signal-detection tools. Thanks to diligent effort, microbial opsins have been engineered to provide desirable tradeoffs with respect to light sensitivity and expression level as well as the timing and magnitude of physiological effect. Gene constructs are available that permit the targeting of specific neuronal cell types. And optrodes, implantable devices that are capable of both optical neuromodulation (via fiber optics and laser diodes) and electrical recording (via electrodes), have been developed that hardly impede the self-directed movements of live animals.

  • Dissecting Neural Circuits

    Optogenetics may be used for the temporally and spatially precise activation or deactivation of specific kinds of neurons. But that’s hardly the point. What’s really interesting is seeing how neuronal signaling propagates from neuron to neuron, or through clusters of neurons. Such signaling is optogenetically initiated when an ion channel or pump, stimulated by light, shuttles ions across a membrane, setting up an action potential, an electrical signal that triggers the release of neurotransmitters. It is also possible to target neuromodulatory neurons, which release dopamine or serotonin.

    Signals that propagate through a neural circuit may be traced by means of electrode recording, calcium imaging, and other neural activity readout methodologies. Neural activity may also be correlated with functional magnetic resonance imaging. Of particular interest, to judge by the volume of news coverage, are the connections between specific kinds of neural stimulation and changes in the behaviors of lab animals.

    Here is a sampling of recently announced optogenetic behavioral studies in animals:

    • Researchers at the University of North Carolina School of Medicine asserted that they had pinpointed the precise cellular connections responsible for overeating. By optogenetically stimulating gaba neurons in the bed nucleus of the stria terminalis (BNST), the researchers caused well-fed mice to eat voraciously. Shutting down the BNST pathway caused the mice to show little interest in eating, even if they had been deprived food.
    • A team of scientists based at the Douglas Mental Health University Institute reported that they had identified a precise causal link between neuronal activity in the lateral hypothalamus and the state of REM sleep.
    • Rather than focus on principal neurons, which are excitatory, researchers at Cold Spring Harbor Laboratory widened their view to take in interneurons, which are inhibitory. This approach helped the researchers discover that certain inhibitory neurons—that is, neurons expressing vasoactive intestinal polypeptide (VIP)—specialize in inhibiting other inhibitory neurons in multiple regions of cortex, and does so under specific behavioral conditions.
    • INSERM-based scientists were able to demonstrate that fear expression is related to the inhibition of highly specific interneurons—the parvalbumin-expressing prefrontal interneurons. More specifically, inhibition of their activity disinhibits the activity of the prefrontal projection neurons, and synchronizes their action.
    • At Wake Forest Baptist Medical Center, researchers selectively controlled a specific population of dopamine cells in the ventral tegmental area that serves as part of the brain-reward system. Using this technique, the researchers discovered distinct pattern of dopamine cell activation that seemed to be able to disrupt alcohol-drinking behavior.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?